Gland Pharma has reported result for first quarter ended June 30, 2025 (Q1FY26).
The company has reported 20.79% rise in its net profit at Rs 269.26 crore for the quarter ended June 30, 2025 as compared to Rs 222.92 crore for the same quarter in the previous year. The total income of the company increased by 3.12% at Rs 1093.58 crore for Q1FY26 as compared to Rs 1060.51 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 49.89% jump in its net profit at Rs 215.48 crore for Q1FY26 as compared to Rs 143.76 crore for the same quarter in the previous year. The total income of the company increased by 7.57% at Rs 1563.15 crore for Q1FY26 as compared to Rs 1453.14 crore for the corresponding quarter previous year.
